Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: Value of FDG volumetric imaging parameters

To evaluate whether the change in the metabolic tumour volume (MTV) or total lesion glycolysis (TLG) of the primary tumour, before and after induction chemotherapy, predicts outcome for patients with advanced head and neck squamous cell cancer (SCC).

[1]  Kristin D. Brockway,et al.  What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. , 2012, International journal of radiation oncology, biology, physics.

[2]  M. Kikuchi,et al.  Sequential FDG-PET/CT after Neoadjuvant Chemotherapy is a Predictor of Histopathologic Response in Patients with Head and Neck Squamous Cell Carcinoma , 2011, Molecular Imaging and Biology.

[3]  B. C. Penney,et al.  Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Chun-Ta Liao,et al.  Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma. , 2013, Oral oncology.

[5]  Jeanne Kowalski,et al.  Assessment of Interobserver Reproducibility in Quantitative 18F-FDG PET and CT Measurements of Tumor Response to Therapy , 2009, Journal of Nuclear Medicine.

[6]  Florent Tixier,et al.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  A. Ozonoff,et al.  FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site , 2012, Nuclear medicine communications.

[8]  I. Kayani,et al.  The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  K. Frey,et al.  Advanced squamous cell carcinoma of the oropharynx: Efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy , 2009, Head & neck.

[10]  J. Bourhis,et al.  [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]. , 2009, Bulletin du cancer.

[11]  M. Truong,et al.  Fluorodeoxyglucose–Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer , 2010, American Journal of Neuroradiology.

[12]  Su Jin Lee,et al.  Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma , 2009, Annals of Surgical Oncology.

[13]  I. Buvat,et al.  Comparative Assessment of Methods for Estimating Tumor Volume and Standardized Uptake Value in 18F-FDG PET , 2010, Journal of Nuclear Medicine.

[14]  Rathan M. Subramaniam,et al.  18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging , 2012, The Journal of Nuclear Medicine.

[15]  R. Boellaard,et al.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  M. Borri,et al.  Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  R. Subramaniam,et al.  Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods , 2012, Annals of Nuclear Medicine.

[18]  M. M. Qureshi,et al.  A Prognostic Volumetric Threshold of Gross Tumor Volume in Head and Neck Cancer Patients Treated With Radiotherapy , 2014, American journal of clinical oncology.

[19]  Baosheng Li,et al.  Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  G. Calais,et al.  Induction chemotherapy in head and neck cancer: a new paradigm , 2011, Anti-cancer drugs.

[21]  B. C. Penney,et al.  Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. , 2013, Academic radiology.

[22]  D. Appelbaum,et al.  Interobserver variability among measurements of the maximum and mean standardized uptake values on 18F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors , 2010, Acta radiologica.

[23]  A. Ozonoff,et al.  Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. , 2011, AJR. American journal of roentgenology.

[24]  A. Clayton,et al.  Hibernoma: 18F FDG PET/CT imaging. , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  Barry A Siegel,et al.  Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Jett,et al.  18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma * , 2009, Journal of medical imaging and radiation oncology.

[27]  Quynh-Thu Le,et al.  Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. , 2012, International journal of radiation oncology, biology, physics.

[28]  B. O'neill,et al.  Contribution of F-18 FDG PET-CT in the Detection of Systemic Spread of Primary Central Nervous System Lymphoma , 2007, Clinical nuclear medicine.